The performance of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key markets has introduced significant uncertainty . Investors are now assessing the effect of rival medi